Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2001

View Archived Issues

Incara's porphyrin-based catalytic antioxidant is neuroprotective in ischemia

Dual PPAR agonist shows good preclinical results

Companies form strategic agreement to develop asthma and allergic rhinitis products

Preliminary animal studies indicate that Oxycyte may be safer than other PFC emulsions

Final results of PH-10 pilot study in the treatment of plaque psoriasis reported

Theratechnologies submits IND application to Health Canada for ThGRF1-44

Osteoarthritis product launched in Europe

Biora enters distribution agreement with USBiomaterials for new periodontal disease product

New selective dopamine D4 complete antagonist reported

Genetically modified neural stem cells may be useful in the treatment of PD

Avanir acquires technology to develop MIF modulators

Roche receives first approval for PEGASYS

Schering AG acquires rights to fasudil in the U.S. and Europe

Antalarmin inhibits stress-induced gastric ulceration in rats

New cathepsin and calpain inhibitors and their use described by Senju

Urokinase inhibitors with antiangiogenic activity reported by Abbott

Kyoto Pharmaceutical reports new derivatives with glucose- and triglyceride-lowering activity

Novel thrombin inhibitors presented by Akzo Nobel

Sumitomo describes new compounds for the treatment of inflammation and autoimmune diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....